Table 2 Characteristics of study population with respect to HBV status
From: Sero-prevalence of HBsAg in naive HIV-infected patients in a rural locality of Cameroon
HIV mono-infected N (%) | HBV co-infected N (%) | P-value | |
|---|---|---|---|
Sex | 0.953 | ||
Male | 180 (27.8) | 18 (28.1) | |
Female | 468 (72.2) | 46 (71.9) | |
Age group (years) | 0.610 | ||
< 20 | 7 (1.1) | 1 (1.6) | |
20–39 | 345 (53.2) | 38 (59.3) | |
40–59 | 271 (41.8) | 24 (37.5) | |
≥ 60 | 25 (3.9) | 1 (1.6) | |
Year of inclusion | 0.007 | ||
2008 | 75 (11.6) | 4 (6.3) | |
2009 | 67 (10.3) | 3 (4.7) | |
2010 | 108 (16.7) | 3 (4.7) | |
2011 | 129 (19.9) | 15 (23.4) | |
2012 | 109 (16.8) | 12 (18.8) | |
2013 | 124 (19.1) | 20 (31.3) | |
2014 | 36 (5.6) | 7 (10.9) | |
CD4 counts (cells/µL) | 0.365 | ||
< 100 | 188 (29.0) | 24 (37.5) | |
100–199 | 176 (27.2) | 17 (26.6) | |
200–499 | 273 (42.1) | 21 (32.8) | |
≥ 500 | 11 (1.7) | 2 (3.1) | |
ALAT (IU/L) | 0.056 | ||
N | 478 (73.8) | 55 (85.9) | |
2N | 134 (20.7) | 6 (9.4) | |
> 2N | 35 (5.5) | 3 (4.7) | |
ASAT (IU/L) | 0.221 | ||
N | 393 (61.0) | 46 (71.9) | |
2N | 196 (30.5) | 14 (21.9) | |
> 2N | 55 (8.5) | 4 (6.2) | |
Total | 648 | 64 | |